Position in ALKS
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$23,218,803
+$4,680,441 QoQ
Shares Held
443,107
-15.5% QoQ
Ownership
0.264%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#58
of 424 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 0%
Shared 90%
None 10%
Common Shares in ALKS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Invesco Ltd. holds $1,945,758,306 across 45 Drug Manufacturers - Specialty & Generic names. ALKS ranks #15 (1.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
5,523,018 | $396,884,069 | |
| 2 | VTRS |
Viatris Inc
|
20,771,275 | $329,847,840 | |
| 3 | UTHR |
UNITED THERAPEUTICS Corp
|
473,109 | $256,344,645 | |
| 4 | NBIX |
Neurocrine Biosciences Inc
|
1,077,317 | $181,571,000 | |
| 5 | ELAN |
Elanco Animal Health Inc
|
5,306,326 | $130,588,679 | |
| 6 | TEVA |
Teva Pharmaceutical Industries Ltd
|
3,430,011 | $116,208,767 | |
| 7 | INDV |
Indivior Pharmaceuticals, Inc.
|
1,842,983 | $75,617,590 | |
| 8 | COLL |
Collegium Pharmaceutical, Inc
|
1,882,499 | $68,146,461 |
All Filings in ALKS
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $23,218,803 | 443,107 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $18,538,362 | 524,275 | Shares | Defined | 2026-05-12 | |
| 2025-12-31 | $15,073,271 | 538,716 | Shares | Defined | 2026-02-19 | |
| 2025-09-30 | $17,528,790 | 584,293 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $17,538,585 | 613,023 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $24,286,074 | 735,496 | Shares | Defined | 2025-05-12 | |
| 2024-12-31 | $20,762,300 | 721,916 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $21,022,837 | 751,084 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $16,779,380 | 696,240 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $16,250,199 | 600,303 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $23,578,664 | 849,988 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $11,004,175 | 392,866 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $12,558,873 | 401,242 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $12,101,768 | 429,293 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $12,399,624 | 474,536 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $10,068,840 | 450,911 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $17,003,892 | 570,792 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $14,300,825 | 543,551 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $11,930,704 | 512,928 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $13,631,403 | 442,004 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $18,941,233 | 772,481 | Shares | Defined | 2021-08-17 | |
| 2021-03-31 | $14,356,587 | 768,554 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $12,129,159 | 607,978 | Shares | Defined | 2021-02-16 | |
| 2020-06-30 | $4,483,088 | 230,968 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $8,212,261 | 569,505 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||